BMY vs BRK.B · P/E 17, rev $24.46B vs rev $371.44B
Bristol-Myers Squibb Company (BMY) versus BRK.B (BRK.B) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
BRK.B (BRK.B) common stock. It is led by Warren Buffett.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported BRK.B revenue for 2025-12-31 was $371.44B. Net income was $66.97B. Revenue was up 616.8% from 2015-12-31 to 2025-12-31. BRK.B currently screens at market cap $0.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. BRK.B currently screens at market cap $0.
Not investment advice. Open the BMY and BRK.B stock pages for the full models.
Not investment advice.